Serum zinc-alpha(2)-glycoprotein concentrations in patients with non-alcoholic fatty liver disease

Yılmaz Y., Yonal O., Eren F., Kurt R., Celikel Ç., Ozdogan O., ...Daha Fazla

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, cilt.49, sa.1, ss.93-97, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 49 Sayı: 1
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1515/cclm.2011.022
  • Dergi Adı: CLINICAL CHEMISTRY AND LABORATORY MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.93-97
  • Anahtar Kelimeler: enzyme-linked immunosorbent assay, non-alcoholic fatty liver disease, zinc-alpha(2)-glycoprotein, METABOLIC SYNDROME
  • Marmara Üniversitesi Adresli: Evet

Özet

Background: Evidence suggests that zinc-alpha(2)-glycoprotein (ZAG) might serve as a biomarker for human metabolic alterations. We measured serum ZAG in patients with nonalcoholic fatty liver disease (NAFLD), a hepatic manifestation of the metabolic syndrome, and examined its association with clinical, biochemical, and histological phenotypes.